美国FDA 指导原则 第2A阶段会议结束 英文原版.pdfVIP

Guidance for Industry End-of-Phase 2A Meetings U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) September 2009 Procedural Guidance for Industry End-of-Phase 2A Meetings Additional copies are available from: Office of Training and Communication Divisi